PRINCETON, N.J., Feb. 13, 2025 (GLOBE NEWSWIRE) -- Sonnet BioTherapeutics Holdings, Inc. (the "Company” or "Sonnet”) (NASDAQ: SONN), a clinical-stage company developing targeted immunotherapeutic ...

Inventiva is a public company listed on compartment B of the regulated market of Euronext Paris (ticker: IVA, ISIN: ...

Nintendo announced its financial results for its third fiscal quarter ended December 31, with hardware sales of the Switch ...

Gov. Josh Stein is asking the N.C. General Assembly for $1 billion in Helene storm recovery money this spring to help Western ...

But if its executives, including its brand-new CEO, are nervous ... of $409 million were down 60% from the year before. And ...

UK CPI (Jan) – 19/02 – having cut interest rates by 25bps at its recent meeting the Bank of England will be hoping that the ...

Net cash generated from financing activities for 2024 amounted to €145.6 million, compared to €29.1 million in 2023 ... information for Inventiva’s fiscal year ended December 31, 2024 ...

Pioneering license agreement with BrainTransporter signed with BMS worth up to USD 1.35 billion plus royalties Events during the fourth quarter 2024 The Australian Medicines Agency (TGA) decided not ...

Trump Picks New SEC Head, SEC Enforcement Starts Strong in 2025, and Latest Lessons from EXAMS: Details Matter and Duty of ...

A de Blasio-era homeless outreach program has quietly cut its operations in half in the last year due to a city hiring freeze ...

Lesaka Technologies faces a slump despite growth execution and guidance updates. Read here for an investment analysis of LSAK ...